[Toxoplasmosis]

Toxoplasmic encephalitis (TE) is a life-threatening opportunistic infection of the central nervous system caused by reactivation of the protozoan parasite Toxoplasma gondii. Although infection is widespread and typically asymptomatic in immunocompetent individuals, TE predominantly affects those with severe cellular immunodeficiency, particularly individuals with acquired immunodeficiency syndrome and CD4 counts below 100 cells/μL. Key aspects of TE include epidemiology, the parasite life cycle, and the pathophysiology of latent cyst reactivation in the brain. Clinical presentation commonly includes headache, fever, focal neurological deficits, seizures, and altered mental status. A significant diagnostic challenge involves differentiating TE from primary central nervous system lymphoma as both may present with ring-enhancing lesions on neuroimaging. Diagnosis relies on serologic testing, cerebrospinal fluid analysis for T. gondii DNA, and characteristic magnetic resonance imaging findings, such as the eccentric target sign. Therapeutic strategies include a first-line combination of pyrimethamine and sulfadiazine, alternative regimens, and maintenance therapy. Early diagnosis and prompt initiation of therapy are critical to improving patient outcomes.